LONDON, July 22, 2025 /PRNewswire/ -- Magentic, the AI Agent Platform that hunts and delivers savings across global manufacturing supply chains, today announced a...
Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid-β protofibrils in cerebrospinal fluid,...
ACM President Yannis Ioannidis and SIGGRAPH 2025 Conference Chair Ginger Alford Reflect on the Evolving Partnership Driving AI-Powered Breakthroughs in Graphics and Interactive Technology.
NEW...
The Dor Brothers, a video production entity leveraging AI technology for content creation, have established a substantial digital footprint with over 100 million views...
Sequoia Capital, a prominent venture capital firm with historical investments in Nvidia, Google, and Apple, is currently navigating a complex situation involving internal dynamics...
In a significant development for cryptocurrency regulation, Congress has moved forward with legislation impacting stablecoins, a key area for digital currency markets. The Genius...
WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) announced today that the International Bureau of the World Intellectual Property Organization (WIPO) has published its international patent application (Publication No. WO 2025/129197) titled, "Systems and Methods for Predicting Immunologically Active Peptides with Machine Learning Models."
NEW YORK, July 18, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global technetium-99m market is witnessing substantial...
NEW YORK, July 18, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global technetium-99m market is witnessing substantial...